Clinical significance of insulin resistance

Diabetic Medicine

Volumn 13, Issue 6, 1996, Pages 504-509

  Bell, P M ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Essential hypertension; Insulin resistance; Insulin dependent diabetes mellitus; Non insulin dependent diabetes mellitus

Indexed keywords

ANTIHYPERTENSIVE AGENT; INSULIN;

CORONARY RISK; DOSE RESPONSE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TREATMENT; ISCHEMIC HEART DISEASE; LABORATORY DIAGNOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; REVIEW; RISK FACTOR;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERINSULINISM; HYPERTENSION; INSULIN RESISTANCE; RISK FACTORS; SYNDROME;

EID: 0029894271     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199606)13:6<504::AID-DIA111>3.0.CO;2-P     Document Type: Review

References (86)

1. Kahn CR. Insulin resistance, insulin sensitivity and insulin unresponsiveness: a necessary distinction. Metabolism 1978; 27: 1893-1902.
2. Shipp JC, Cunningham RW, Russell RD, Marble A. Insulin resistance: clinical features natural course and effects of adrenal steroid treatment. Medicine 1965; 44: 165-186.
3. Hollenbeck C, Reaven GM. Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab 1987; 64: 1169-1173.
4. Bogardus C, Lillioja S, Mott DM, Hollenbeck C, Reaven G. Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol 1985; 248: E286-E291.
5. Evans DJ, Murray R, Kissebah AH. Relationship between skeletal muscle insulin resistance, insulin mediated glucose disposal and insulin binding. Effects of obesity and body fat topography. J Clin Invest 1984; 74: 1515-1525.
6. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidem 1993; 137: 959-965.
7. Bergman RN, Prager R, Volund A, Olefsky JM. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycaemic glucose clamp. J Clin Invest 1987; 79: 790-800.
8. De Fronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-E223.
9. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
10. Jarrett RJ. Why is insulin not a risk factor for coronary heart disease? Diabetologia 1994; 37: 945-947.
11. Graf M, Brown V, Richards C, Meissner L, Dunaif A. The independent effects of hyperandrogenemia, hyperinsulinaemia and obesity of lipid and lipoprotein profiles in women. Clin Endocrinol 1990; 33: 119-131.
12. Zimmermann S, Phillips RA, Dunaif A, Finegood DT, Wilkenfeld C, Ardeljan M, et al. Polycystic ovarian syndrome: lack of hypertension despite profound insulin resistance. J Clin Endocrinol Metab 1992; 75: 508-513.
13. Moller DE, O'Rahilly S. Syndromes of severe insulin resistance: clinical and pathophysiological features. In: Moller DE, ed. Insulin Resistance. Chichester: Wiley, 1993: 49-81.
14. Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P, Martin MM, et al. The syndromes of insulin resistance and acanthosis nigricans. N Engl J Med 1976; 294: 739-745.
15. Polonsky KS, Given BD, Hirsch L, Shapiro ET, Tillil H, Beebe C, et al. Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest 1988; 81: 435-441.
16. Rizza RA, Gerich JE, Haymond MW, Westland RE, Hall LD, Clemens AH, et al. Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion and intensified conventional insulin therapy. N Engl J Med 1980; 303: 1313-1318.
17. De Fronzo RA, Hendler R, Simonson D. Insulin resistance is a prominent feature of insulin dependent diabetes. Diabetes 1982; 31: 795-801.
18. Lager I, Lonnroth P, Von Schenck H, Smith U. Reversal of insulin resistance in type I diabetes after treatment with subcutaneous insulin infusion. Br Med J 1983; 287: 1661-1664.
19. Beck-Nielsen H, Richelsen B, Hasling C, Nielsen OH, Heding L, Sorensen NS. Improved in vivo insulin effect during continuous subcutaneous insulin infusion in patients with IDDM. Diabetes 1984; 33: 832-837.
20. 3H] glucose. Differences in apparent pattern of insulin resistance depending on isotope used. J Clin Invest 1986; 78: 1479-1486.
21. Ginsberg H, Kimmerling G, Olefsky JM, Reaven GM. Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycaemia. J Clin Invest 1975; 55: 454-461.
22. Barrett EJ, De Fronzo RA, Bevilacqua S, Ferrannini E. Insulin resistance in diabetic ketoacidosis. Diabetes 1982; 31: 923-928.
23. Luzi L, Barrett EJ, Groop L, Ferrannini E, De Fronzo RA. Metabolic effects of low dose insulin therapy on glucose metabolism in diabetic ketoacidosis. Diabetes 1988; 37: 1470-1477.
24. Amiel SA, Sherwin RS, Simonsen DC, Lauritano AL, Tamborlane WV. Impaired insulin action in puberty. A contributing factor to poor glycaemic control in adolescents with diabetes. N Engl J Med 1986; 315: 215-219.
25. Ryan EA, O'Sullivan MJ, Skyler JS. Insulin action during pregnancy. Studies with the euglycaemic clamp technique. Diabetes 1985; 34: 380-389.
26. Yki Jarvinen H, De Fronzo RA, Koivisto VA. Normalisation of insulin sensitivity in type 1 diabetic subjects by physical training during insulin pump therapy. Diabetes Care 1984; 7: 520-527.
27. Bak JF, Jacobsen UK, Jorgensen FS, Pedersen O. Insulin receptor function and glycogen synthase activity in skeletal muscle biopsies from patients with insulin dependent diabetes mellitus: effects of physical training. J Clin Endocrinol Metab 1989; 69: 158-164.
28. Ebeling P, Tuominen JA, Bourey R, Koranyi L, Koivisto VA. Athletes with IDDM exhibit impaired metabolic control and increased lipid utilization with no increase in insulin sensitivity. Diabetes 1995; 44: 471-477.
29. Attvall S, Eriksson B-M, Fowelin J, von Schenk H, Lager I, Smith U. Early posthypoglycaemic insulin resistance in man is mainly an effect of β2 adrenergic stimulation. J Clin Invest 1987; 80: 437-442.
30. Fowelin J, Attvall S, von Schenck H, Smith U, Lager I. Combined effect of growth hormone and cortisol on late post hypoglycaemic insulin resistance in humans. Diabetes 1989; 38: 1357-1364.
31. Butterfield WJH, Whichelow MJ. Peripheral glucose metabolism in control subjects and diabetic patients during glucose, glucose-insulin and insulin sensitivity tests. Diabetologia 1965; 1: 43-53.
32. Rizza RA, Mandarino LJ, Gerich JE. Mechanism and significance of insulin resistance in non-insulin-dependent diabetes mellitus. Diabetes 1981; 30: 990-995.
33. Firth RG, Bell PM, Marsh HM, Hansen I, Rizza RA. Postprandial hyperglycaemia in patients with noninsulin dependent diabetes mellitus. Role of hepatic and extrahepatic tissues. J Clin Invest 1986; 77: 1525-1532.
34. De Fronzo RA. The triumverate: beta cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988; 37: 667-687.
35. Cahill GF. Beta-cell deficiency, insulin resistance, or both. N Engl J Med 1988; 318: 1268-1270.
36. Bogardus C, Lillioja S, Nyomba BL, Zurlo F, Swinburn B, Esposito-Del Puente A, et al. Distribution of in vivo insulin action in Pima Indians as mixture of three normal distributions. Diabetes 1989; 38: 1423-1432.
37. Groop LC, Kankuri M, Schalin-Jantti C, Ekstrand A, Nikula-Ijas P, Widen E, et al. Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl J Med 1993; 328: 10-14.
38. Leslie RDG, Volkmann HP, Poncher M, Hanning I, Orskov H, Alberti KGMM. Metabolic abnormalities in children of noninsulin dependent diabetics. Br Med J 1986; 293: 840-842.
39. Eriksson J, Franssilla-Kallunki A, Ekstrand A, Salovanta C, Widen E, Schalin C, et al. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 1989; 321: 337-343.
40. O'Rahilly S, Turner RC, Matthews DR. Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N Engl J Med 1988; 318: 1225-1330.
41. Peiris AN, Stagner JI, Vogel RL, Nakagawa A, Samols E. Body fat distribution and peripheral insulin sensitivity in healthy men: role of insulin pulsatility. J Clin Endocrinol Metab 1992; 75: 290-294.
42. Hunter S, Ennis CN, Sheridan B, Atkinson AB, Bell PM. Insulin pulsatility and insulin resistance in NIDDM and normal man. Diabetic Med 1994; 11 (suppl 2): S19.
43. Saad M, Knowler WC, Pertitt DJ, Nelson RG, Mott DM, Bennett PH. Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes. Lancet 1989; i: 1356-1358.
44. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25 year follow-up study. Lancet 1992; 340: 925-929.
45. Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 1994; 331: 1188-1193.
46. Ohlson LO, Larsson B, Svardsudd K, Welin L, Eriksson H, Wilhemsen L, et al. The influence of body fat distribution on the incidence of diabetes mellitus: 13.5 years follow up of the participants in the study of men born in 1913. Diabetes 1985; 34: 1055-1058.
47. Zimmett PZ. The pathogenesis and prevention of diabetes in adults. Diabetes Care 1995; 18: 1050-1064.
48. Henry RR, Wiest-Kent TA, Scheaffer L, Kolterman OG, Olefsky JM. Metabolic consequences of very low calorie diet therapy in obese non-insulin dependent diabetic and nondiabetic subjects. Diabetes 1986; 35: 155-164.
49. Friedenberg GR, Reichart D, Olefsky JM, Henry RR. Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin dependent diabetes mellitus. Effect of weight loss. J Clin Invest 1988; 82: 1398-1406.
50. Brunzell JD, Lerner RL, Hazzard WR, Porte D, Bierman EL. Improved glucose tolerance with high carbohydrate feeding in mild diabetics. N Engl J Med 1971; 284: 521-524.
51. Coulston AM, Hollenbeck CB, Swislocki ALM, Chen Y-DI, Reaven GM. Deleterious metabolic effects of high carbohydrate, sucrose containing diets in patients with non-insulin-dependent diabetes mellitus. Am J Med 1987; 82: 213-220.
52. Scarlett JA, Gray RS, Griffin J, Olefsky JM, Kolterman OG. Insulin treatment reverses the insulin resistance of type II diabetes mellitus. Diabetes Care 1982; 5: 353-363.
53. Foley JE, Kashiwagi A, Verso MA, Reaven G, Andrews J. Improvement in in vitro insulin action after one month of insulin therapy in obese non insulin dependent diabetics: measurements of glucose transport and metabolism, insulin binding and lipolysis in isolated adipocytes. J Clin Invest 1983; 72: 1901-1909.
54. Kolterman OG, Gray RS, Shapiro G, Scarlett JA, Griffin J, Olefsky JM. The acute and chronic effects of sulphonylurea therapy in type II diabetic subjects. Diabetes 1984; 33: 346-354.
55. Simonson DC, Ferrannini E, Bevilacqua S, Smith D, Barrett E, Carlson R, et al. Mechanism of improvement in glucose metabolism after chronic glyburide therapy. Diabetes 1984; 33: 838-845.
56. Lord JM, White SI, Baily CJ, Atkins TW, Fletcher RF, Taylor KG. Effect of metformin on insulin receptor binding and glycaemic control in type II diabetes. Br Med J 1983; 286; 830-831.
57. Perriello G, Misericordia P, Volpi E, Santucci A, Santucci C, Ferrannini E, et al. Acute antihyperglycaemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes 1994; 43: 920-928.
58. Andrews WJ, Vasquez B, Nagulesparan M, Klimes I, Foley J, Unger R, et al. Insulin therapy in obese noninsulin dependent diabetes mellitus induces improvements in insulin action and secretion that are maintained for two weeks after insulin withdrawal. Diabetes 1984; 33: 634-642.
59. Firth RG, Bell PM, Rizza RA. Effect of tolazamide and exogenous insulin on insulin action in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1986; 314: 1280-1286.
60. Rossetti L, Smith D, Shulman GI, Papachristou D, De Fronzo RA. Correction of hyperglycaemia with phlorizin normalises tissue sensitivity to insulin in diabetic rats. J Clin Invest 1987; 79: 1510-1515.
61. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, et al. Hyperinsulinaemia, a link between hypertension, obesity and glucose intolerance. J Clin Invest 1985; 75: 809-817.
62. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, et al. Insulin resistance and essential hypertension. N Engl J Med 1987; 317: 350-357.
63. Rooney DP, Neely RDG, Ennis CN, Bell NP, Sheridan B, Atkinson AB, et al. Insulin action and hepatic glucose cycling in essential hypertension. Metabolism 1992; 41: 317-324.
64. Capaldo B, Lembo G, Napoli R, Rendina V, Albano G, Sacca L, et al. Skeletal muscle is a primary site of insulin resistance in essential hypertension. Metabolism 1991; 40: 1320-1322.
65. Saad MF, Lillioja S, Nyomba BL, Castillo C, Ferraro R, De Gregorio M, et al. Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med 1991; 324: 733-739.
66. Beatty O, Harper R, Sheridan B, Atkinson AB, Bell PM. Insulin resistance in offspring of hypertensive parents. Br Med J 1993; 307: 92-96.
67. Rooney DP, Edgar JDM, Sheridan B, Atkinson AB, Bell PM. The effects of low dose insulin infusions on the renin angiotensin and sympathetic nervous systems in normal men. Eur J Clin Invest 1991; 21: 430-435.
68. De Fronzo RA. The effect of insulin on renal sodium metabolism. Diabetologia 1981; 21: 165-171.
69. Christensen NJ. Acute effects of insulin on cardivascular function and nonadrenaline uptake and release. Diabetologia 1983; 25: 377-381.
70. Julius S, Gudbrandsson T, Jamerson K, Shahab T, Andersson O. The haemodynamic link between insulin resistance and hypertension. J Hypertens 1991; 9: 983-986.
71. Lewis PJ, Kohner EM, Petrie A, Dollery CT. Deterioration of glucose tolerance in hypertensive patients on prolonged diuretic therapy. Lancet 1976; 1: 564-566.
72. Skarfors ET, Lithell HO, Selinus I, Aberg H. Do antihypertensive drugs precipitate diabetes in predisposed men? Br Med J 1989; 298: 1147-1152.
73. Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorthiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 1989; 321: 868-873.
74. Pollare T, Lithell H, Selinus I, Berne C. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. Br Med J 1989; 298: 1152-1157.
75. Harper R, Ennis CN, Sheridan B, Atkinson AB, Johnston GD, Bell PM. Effects of low dose versus conventional dose thiazide diuretic on insulin action in essential hypertension. Br Med J 1994; 309: 226-230.
76. Harper R, Ennis CN, Heaney AP, Sheridan B, Gormley M, Atkinson AB, et al. A comparison of the effects of low and conventional dose thiazide diuretic on insulin action in hypertensive patients with NIDDM. Diabetologia 1995; 38: 853-859.
77. Hunter SJ, Harper R, Ennis C, Crothers E, Johnston GD, Sheridan B, et al. Effect of captopril used either alone or in combination with a diuretic on insulin action in essential hypertension. J Endocrinol 1995; 144 (suppl): 313.
78. MacMahon SW, Macdonald GJ, Blacket RB. Plasma lipoprotein levels in treated and untreated hypertensive men and women. Arteriosclerosis 1985; 5: 391-396.
79. The Working Group on Hypertension in Diabetes. Statement on hypertension in diabetes mellitus. Arch Intern Med 1987; 147: 830-842.
80. Kissebah AH. Insulin resistance in visceral obesity. Int J Obesity 1991; 15: 109-115.
81. Pyorala K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 1979; 2: 131-141.
82. Ducimetiere P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle aged population. Diabetologia 1980; 19: 205-210.
83. Juhan-Vague I, Alessi I, Vague P. Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis. Diabetologia 1991; 34: 457-462.
84. Stout RW. Experimental atherosclerosis and diabetes mellitus. In: Stout RW, ed. Diabetes and Atherosclerosis. Dordrecht: Kluwer, 1992: 267-291.
85. Wingard DL, Ferrara A, Barrett-Conner EL. Is insulin really a heart disease risk factor? Diabetes Care 1995; 18: 1299-1304.
86. Stern MP. The insulin resistance syndrome: the controversy is dead, long live the controversy. Diabetologia 1994; 37: 956-958.